Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.

ABSTRACT:

SUBMITTER: Voruz S 

PROVIDER: S-EPMC5777214 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature